Displaying 1 - 11 of 11
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Why we need to talk about NASH

Why we need to talk about NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Hepatic consequences of metabolic dysregulation: NAFLD and NASH

Hepatic consequences of metabolic dysregulation: NAFLD and NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Looking ahead: how to identify high-risk patients

Looking ahead: how to identify high-risk patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating the NASH healthcare system: global insights and challenges (panel discussion and Q&A)

Navigating the NASH healthcare system: global insights and challenges (panel discussion and Q&A)

Webcasts
View
Metabolism, Alcohol & Toxicity
The NASH treatment pipeline: focus on anti-metabolic approaches

The NASH treatment pipeline: focus on anti-metabolic approaches

Webcasts
View